Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-1-24
pubmed:abstractText
Chronic rejection is a major problem for all lung transplant programmes, which is functionally manifested by fixed airflow limitation, Bronchiolitis Obliterans Syndrome (BOS). The inclusion of a Pre-BOS category, BOS(0 approximately p), in newly revised guidelines, recognizes the potential importance of early changes. We have previously demonstrated reticular basement membrane (Rbm) thickening in clinically stable lung transplant recipients free from BOS. The present study extends this, testing the hypothesis that inhaled corticosteroid (ICS) therapy will lead to a decrease in Rbm thickness in lung transplant recipients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0954-7894
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1905-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15663566-Adolescent, pubmed-meshheading:15663566-Adrenal Cortex Hormones, pubmed-meshheading:15663566-Adult, pubmed-meshheading:15663566-Basement Membrane, pubmed-meshheading:15663566-Betamethasone 17-Valerate, pubmed-meshheading:15663566-Bronchi, pubmed-meshheading:15663566-Bronchiolitis Obliterans, pubmed-meshheading:15663566-Bronchoscopy, pubmed-meshheading:15663566-Chronic Disease, pubmed-meshheading:15663566-Female, pubmed-meshheading:15663566-Graft Rejection, pubmed-meshheading:15663566-Humans, pubmed-meshheading:15663566-Lung Transplantation, pubmed-meshheading:15663566-Male, pubmed-meshheading:15663566-Middle Aged, pubmed-meshheading:15663566-Nebulizers and Vaporizers, pubmed-meshheading:15663566-Statistics, Nonparametric, pubmed-meshheading:15663566-Transplantation, Homologous, pubmed-meshheading:15663566-Treatment Failure
pubmed:year
2004
pubmed:articleTitle
Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids.
pubmed:affiliation
Applied Immunobiology and Transplantation Group, Freeman Hospital and University of Newcastle-upon-Tyne, Newcastle-upon-Tyne NE7 7DN, UK. Chris.Ward@newcastle.ac.uk
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't